Background: Visual processing deficits have been reported for patients with schi zophrenia. Previous studies demonstrated differences in earlystage processing of schizophrenics, although the nature, extent, and localization of the disturbance are unknown. The magnocellular and parvocellular visual pathways are associa ted with transient and sustained channels, but their respective contributions to schizophreniarelated visual deficits remains controversial. Purpose: The aim of this study was to evaluate magnocellular dysfunction in schi zophrenia using frequency doubling technology. Methods: Thirtyone patients with schizophrenia and 34 healthy volunteers were examined. Frequency doubling technology testing was performed in one session, consisting of a 15minute screening strategy followed by the C20 program for frequency doubling technology. Results: Schizophrenic patients showed lower global mean sensitivity (30,97 ± 2,25 dB) compared with controls (32,17 ± 3,08 dB), p<0.009. Although there was no difference in the delta sensitivity of hemispheres, there was a difference in sensitivity analysis of the fibers crossing the optic chiasm, with lower mean sensitivity in the patient group (28,80 dB) versus controls (30,66 dB). The difference was higher in fibers that do not cross the optic chiasm, with lower mean sensitivity in patients (27,61 dB) versus controls (30,26 dB), p<0.005. Conclusions: Our results suggest that there are differences between global sen sitivity and fiber sensitivity measured by frequency doubling technology. The different sensitivity of fibers that do not cross the optic chiasm is consistent with most current etiological hypotheses for schizophrenia. The decreased sensitivity responses in the optic radiations may significantly contribute to research assessing earlystage visual processing deficits for patients with schizophrenia.
INTRODUCTION
Schizophrenia is a severe mental disorder and considered a pu blic health issue. The cost of schizophrenia includes lost income, public aid, and drug and psychosocial treatments (1) . Despite all the treatments currently available, patients with schizophrenia still suffer from a combination of symptoms, such as delusions, hallucinations, and social withdrawal (1, 2) . Among many hypotheses for schizophrenia's etiology, the neu rodevelopmental model is one of the most important (3) . The visual pathway may be a good marker for central nervous system develop ment. The recent advances in understanding the neural networks involved in visual perception allow a better comprehension of the pa thophysiology of neurodevelopmental and psychiatric disorders (4, 5) . Schizophrenia patients' exhibit deficits in several neurophysiolo gic measures of information processing that have been proposed as candidate endophenotypes (6) . A number of studies that provide evi dence to support the hypothesis that the deficit in the magnocellular pathway is a trait of vulnerability to schizophrenia (7, 8) . Deficits in visual performance of patients with schizophrenia have been described for many years, but this may be due to several factors, from peripheral sensory abnormalities (slow neuronal trans mission) to losses in higher cortical functioning (6, 911) . Furthermore, fai lures in this system cause a lack of information to the visual cortex, and these result in clinical symptoms for patients (12) . The most frequent clinical symptoms include selective attention in sustained attention and disturbance of shortterm visual memory (1315) . The subcortical projections of the retina to the cerebral cortex are formed mainly by two pathways (magnocellular and parvocellular) related to subdivisions of the lateral geniculate body with the same name. These pathways are of great importance because they contain approximately 90% of axons leaving the retina and maintain their anatomical segregation of projections through the lateral geniculate body in the V1 layer 4C of the striate cortex (14) . Psychophysical studies of specific visual functions have been used to measure visual performance and understand retinal ganglion cell functioning. Some studies suggested that the visual deficit is in the magnocellular pathway, or the transient channels. Other studies claim that the visual deficit is in the parvocellular pathway or the sustained channels, or the interaction of the abnormal magnocellular and parvocellular channels (1618) . Although many studies have establi shed that there are differences in early visual processing in schizo phrenia patients, the nature, extent, and location of this abnormality remain uncertain (19, 20) . The magnocellular pathway is formed by large neurons that pro ject the visual stimuli to the dorsal visual stream, and is primarily involved with the motion and location of the stimulus (the "where" system) (20) . The parvocellular pathway is composed of smaller neu rons, with slower neuronal driving, which project to the ventral visual stream and is primarily responsible for recognition of the object (the "what" system). Despite the preference of the dorsal and ventral mag nocellular and parvocellular neurons, visual information also crosses between hemispheres (20) . The physiological responses of ganglion cells in the magnocel lular and parvocellular pathways are similar in some domains and completely different in others. The major difference is the response to color sensitivity. Parvocellular neurons respond to the stimulus of alternation green/red or blue/yellow, and show some response des pite the change of color luminescence. In the case of magnocellular neurons, there is no response to alternation of colors when the lumi nescence is balanced (21) . Another difference in physiological responses between parvo cellular and magnocellular neurons is present in contrast sensitivity. The response to contrast sensitivity is much greater in magnocellular cells, which respond to stimuli with contrast less than 2%, while the parvocellular cells rarely respond to a contrast less than 10% (20, 21) .In other dimensions of visual stimuli, including spatial response, tem poral, and luminescence contrast, neurons via the parvocellular and magnocellular pathways have different responses; however, there is overlap in the rates of sensitivity (20) . The aim of this study was to evaluate the initial visual processing (perception of the stimulus by ganglion cells) using frequency dou bling technology (FDT) in patients with schizophrenia compared with healthy controls, and evaluate the relationship between the deficit in visual processing with sociodemographic factors and cli nical factors associated with chronicity, such as negative symptoms, duration of the disease, and antipsychotic drug use.
METHODS

ParticiPants
We recruited patients with diagnoses of schizophrenia from the Schizophrenia Program at the Federal University of São Paulo. The control group was recruited from the hospital staff community and students at the same university. The participation of individuals in the study was voluntary and all signed the Term of Free and Informed Consent, previously approved by the Ethics Committee of the Federal University of São Paulo.
Inclusion criteria for patients included: 1) fulfill the diagnosis of schi zophrenia made through the application of the Structured Cli nical Interview for DSM-IV (SCID) by a trained psychiatrist; 2) good vision (visual acuity greater 20/60) tested by Snellen chart; 3) intrao cular pressure lower than 20 mmHg measured by Perkins tonometry; and 4) normal biomicroscopic examination and normal optic nerve (excavation/disc equal to or less than 0.6 SD) assessed by a ophthal mologist (22) . The exclusion criteria for patients included: 1) presence of a his tory of abuse on alcohol or drugs; 2) presence of any neurological disease that could affect performance on the test; and 3) diseases aff ecting the visual field.
The inclusion criteria for controls: 1) mental status assessment by SelfReport Questionnaire (SRQ20) with cutoff less than or equal to 7 positive answers; and 2) the same ophthalmologic inclusion criteria applied for the schizophrenic patients. A family history of glaucoma was allowed (23) . The exclusion criteria for controls: 1) presence of psychiatric illness; 2) substance abuse; 3) diseases affecting the visual field; and 4) presen ce of a systemic disease that can potentially affect the visual system.
Psychiatric assessment
The presence of positive and negative symptoms was assessed by the Positive and Negative Syndromes Scale (PANSS) (24) . Schizoph renic patients were classified into negative, positive, or mixed accor ding to the parameters of Andreasen and Olsen (24) . Patients were evaluated and classified according to antipsychotic medication in use. The type of antipsychotics included first and se cond generation antipsychotics or a combination of both. The dose of chlorpromazine equivalents for each antipsychotic used at the time of examinations was calculated.
Control participants were evaluated with the SRQ20 and were excluded from the study if their scores were higher than 7.
OPhthalmOlOgic evaluatiOn
Participants were submitted to an ophthalmological examina tion, which included: measurement of visual acuity, refraction, slitlamp biomicroscopy of the anterior chamber, measurement of intraocular pressure, and fundus examination.
Patients and volunteers were tested: light stimuli were presented and participants responded according to their ability to detect the stimuli. Participants first received the necessary instructions for per forming the examination. Next, participants began a 15minute stra tegy of screening, where participants learned to recognize the stimuli and adapt to the test. The stimuli were presented on the computer screen and the participants were required to press a button when they saw the gray square. Testing was conducted in a darkened room.
FDT measures the contrast needed for detection of the stimulus. Each grating target is a square extending approximately 10º in diame ter. Targets are presented in one of 18 areas located 20° radius of the visual field temporally and 30º nasally (25) . FDT was performed with the C20 program, which is the proper evaluation of the magnocellular cells, using a sinusoidal pattern of light stimuli and temporal fre quency of 50 Hz (25, 26) . FDT was measured with the frequency doubling visual field instrument (Carl Zeiss Meditec, Dublin, CA).
statistical analysis
The analyses of FDT global retinal sensitivity were performed com paring the meandeviation (MD) of patients versus controls using unpaired t test. The right hemisphere analysis included the mean sensitivity of the right nasal and left temporal hemifields. The left hemisphere analysis included the mean sensitivity of the right tem poral and left nasal hemifields. We also performed a retinal sensitivity analysis between the fibers crossing the optic chiasm and those that do not cross.
Statistical analyses were performed using the SPSS statistical pa ckage, version 17.0, (SPSS Inc., Chicago, USA). Generalized estimated equation (GEE) was performed to evaluate differences among the groups and to correct the dependency between the eyes, accor ding to hemispheres, and fibers that cross or do not cross the optic chiasm (27) . As a secondary analysis, MD values were used as the dependent variable in the logistic regression model with the following indepen dent variables: age, gender, disease duration, antipsychotic treat ment, positive and negative symptoms, and education level.
RESULTS
We evaluated 31 outpatients (24 male/7 female) diagnosed with schizophrenia using the SCID criteria of the DSMIVR, and 34 health controls (8 male/26 female). The participants' sociodemographic characteristics are described in table 1. The ophthalmologic evalua tion revealed that both groups had visual acuity, as tested by Snellen chart, that was higher than 20/60 (Table1). Intraocular pressure was normal (less than 20 mmHg) for both groups, although there was a significant difference between groups of less than 2 mmHg. This difference is not clinically relevant and cannot affect the FDT results.
In the sample studied, only two patients were employed at the time of evaluation; the remaining 32 (94%) were retired or receiving sickness benefit.
All patients were using antipsychotic drugs or other psychotropic agents for at least 6 months. The patients were also assessed by the PANSS scale and classified according to symptomatic group: ten were classified as negative type, ten were positive type, 11 were any kind, and three were mixed type. The participants' clinical characteristics are described in table 2. Table 3 shows the global MD FDT test in control and schizophrenia groups. Three patients were excluded from the FDT analysis due to poor performance on the test.
The patients with schizophrenia showed lower global mean sensitivity values (30.97 dB ± 2.25) in comparison with the control group mean (32.17 dB ± 3.08), p<0.009. There was no difference in the delta sensitivity of hemispheres between patients and controls (p<0.88) (Figure1).
There was a difference in sensitivity analysis of the fibers crossing the optic chiasm between patients and controls, with lower mean sensitivity in the schizophrenia group (28.80 dB) than in the control group (30.66 dB), p=0.005 (Figure 2) .
The difference in sensitivity analysis of the fibers that did not cross the optic chiasm between patients and controls was higher, with lower mean sensitivity (27.61 dB) in the patient group versus (3026 dB) the control group (p=0.02).
There was no significant correlation between the global mean sensitivity values and the following independent variables: age, gen der, length of time with diagnoses, antipsychotics used, presence or absence of positive and negative symptoms, and education level.
DISCUSSION
This study evaluated the visual processing deficits in schizo phrenia by use of FDT. The advantages of FDT for early detection of magnocellular dysfunction are well documented. FDT shows good specificity (86100%) at high sensitivity (93%), and has global indices that correlate highly with those of standard perimetry (26) . The finding in this study of a deficit in the magnocellular pathway in schizophre nia is consistent with results from some previous psychophysical studies, although they have also produced conflicting results (28) . A number of psychophysical tests have been used to measure visual performance and to understand retinal ganglion cell deficits in schizophrenia (8, 28) . Some studies using a visual backward masking paradigm, during which participants are asked to detect a stimulus immediately followed by a mask, increased the possibility that the mask, which is processed by an overactive magnocellular pathway, may influence the lower performances on target detections (18, 29) . Studies using luminance contrast sensitivity measurements sho wed more pronounced differences. Schwartz et al. (15) found selective contrast sensitivity impairments for temporally modulated low fre quency gratings, which stimulate magnocellular neurons. Kéri et al. (30) observed intact contrast sensitivity for magnocellular pathway stimuli.
A limitation of this study is that there has not been extensive tes ting of its psychophysical properties. Furthermore, the impact of training requires better investigation and testretest reliability should be measured, especially in patients with cognitive impairments (31) . New evidence from functional magnetic resonance imaging sup ports the hypothesis that schizophrenia is associated with impaired functioning of the magnocellular pathway and that these deficits may contribute to highorder cognitive deficits (32) . Based on previous available data, it was hypothesized that a negative correlation would be found such that patients with the highest level of negative symptoms would show the greatest deficit in the magnocellular pa thway (33) . In general, the results of the contrast sensitivity and masking studies suggest that visual processing is more intact in groups with predominantly positive symptoms and good premorbid history. In our sample, there was no correlation between length of time with the disease and age of onset.
In this study all patients were using antipsychotic drugs or other psychotropic agents for at least 6 months, and the medication effect cannot be excluded. Dopamine is present in the retina and there is evidence that a hypodopaminergic state could affect contrast sensitivity and color perception (34) . However, previous studies have shown no significant correlations between the antipsychotic dose and deficits in the magnocellular pathway (32, 33) . In contrast, Braff and Saccuzzo (35) found that medications reduced the backward masking deficit. In our sample, there was no correlation between FDT response and chlorpromazineequivalent doses.
There is some evidence in literature that supports a right hemis phere advantage for processing global information, and left hemis phere preference for local information (36) . In our study, there was no difference in the delta sensitivity of hemispheres between patients and controls. However, Braus et al. (37) used functional magnetic re sonance imaging and found a hypoactivation in the magnocellular pathway, particularly in the right hemisphere of schizophrenic pa tients, but found no evidence of abnormal functioning in the area of the parvocellular pathway.
It was possible to verify the difference in sensitivity analysis of the fibers that do not cross the optic chiasm between patients and controls because of the particularities of ganglion cell anatomy (38) . The ganglion cells of the right and left eye visual receptive fields re flect half of the visual field in the opposite hemisphere. The crossing of fibers occurs in the retinal optic chiasm, where medial fibers cross the chiasm to join sides with the temporal fibers. In other words, the temporal retina ipsilateral hemispheric projection displays in the same side, while the nasal retina contralateral hemispheric projection displays in the opposite side. Because of this distribution of fibers, each outer half of the visual field is represented in the opposite ce rebral hemisphere (38) . To the best of our knowledge, this is the first time in the literature that analyses of sensitivity between fibers that cross and do not cross the chiasm have been performed. The evidence presented here, for a lower sensitivity in fibers that do not cross the optic chiasm, is con sistent with most current etiological hypotheses for schizophrenia involving genetic factors and anatomical processes (e.g., dysmyeli nation) (3, 39) . Our study showed significant decreased sensitivity responses in the optic radiations, which was consistent with the results from Butler et al. using diffusion tensor imaging to examine white mat ter integrity in schizophrenia (40) . The present findings suggest that there are differences between global sensitivity and fiber sensitivity measured by FDT, and may contribute to a significant body of re search to assess earlystage visual processing deficits for patients with schizophrenia.
